Effects of silencing annexin A5 on proliferation and invasion of human cholangiocarcinoma cell line.
暂无分享,去创建一个
[1] Y. Bao,et al. The role of hypoxia inducible factor in nasal inflammations. , 2016, European review for medical and pharmacological sciences.
[2] K. Goodman,et al. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma , 2016, Cancer journal.
[3] Qingchang Chen,et al. Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers. , 2016, Acta biomaterialia.
[4] L. Rinaldi,et al. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein. , 2016, European review for medical and pharmacological sciences.
[5] S-J Li,et al. Oxidative stress inhibits growth and induces apoptotic cell death in human U251 glioma cells via the caspase-3-dependent pathway. , 2015, European review for medical and pharmacological sciences.
[6] A. Abrantes,et al. Cholangiocarcinoma: from molecular biology to treatment , 2015, Medical Oncology.
[7] A. Hao,et al. E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling , 2015, Journal of Neuro-Oncology.
[8] Feng Liu,et al. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma , 2015, Cell Biochemistry and Biophysics.
[9] S. Degrelle,et al. Review: Annexin-A5 and cell membrane repair. , 2015, Placenta.
[10] A. Bergquist,et al. Epidemiology of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.
[11] A. Zhu. Future directions in the treatment of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.
[12] Lei Wu,et al. Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells , 2014, Tumor Biology.
[13] M. Sun,et al. Annexin A5 as a potential marker in tumors. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[14] A. Moon,et al. Role of Annexin A5 in Cisplatin-induced Toxicity in Renal Cells , 2013, The Journal of Biological Chemistry.
[15] Jing Zhao,et al. Identification of Molecular Target Proteins in Berberine‐treated Cervix Adenocarcinoma HeLa Cells by Proteomic and Bioinformatic Analyses , 2012, Phytotherapy research : PTR.
[16] C. Larsson,et al. Proteomic profiling of follicular and papillary thyroid tumors , 2011, European journal of endocrinology.
[17] C. Reutelingsperger,et al. Phosphatidylserine targeting for diagnosis and treatment of human diseases , 2010, Apoptosis.
[18] L. Xu,et al. Expression of P-Glycoprotein and Multidrug Resistance-Associated Protein is Associated with Multidrug Resistance in Gastric Cancer , 2010, The Journal of international medical research.
[19] Shuhan Sun,et al. Expression of Annexin A5 Is Associated With Higher Tumor Stage and Poor Prognosis in Colorectal Adenocarcinomas , 2009, Journal of clinical gastroenterology.
[20] M. Sun,et al. Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis , 2009, Proteomics.
[21] Joseph J Bennett. Biliary tract cancers. Preface. , 2009, Surgical Oncology Clinics of North America.
[22] M. Sun,et al. High-performance liquid chromatography/nano-electrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarkers. , 2008, Rapid communications in mass spectrometry : RCM.
[23] C. Reutelingsperger,et al. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. , 2008, Biochimica et biophysica acta.
[24] Y. Qing,et al. Role of Npm1 in proliferation, apoptosis and differentiation of neural stem cells , 2008, Journal of the Neurological Sciences.
[25] Shuqun Cheng,et al. [Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma]. , 2007, Zhonghua yi xue za zhi.
[26] Jagat Narula,et al. Annexin A5 Down-regulates Surface Expression of Tissue Factor , 2005, Journal of Biological Chemistry.
[27] Alphonse E. Sirica,et al. Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.
[28] H. Thomas,et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.
[29] S. Moss,et al. DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Monden,et al. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma. , 2002, Liver.
[31] H. Ogata,et al. Annexin V inhibits the 12-O-tetradecanoylphorbol-13-acetate-induced activation of Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of Shc in MCF-7 cells , 2000, Oncogene.
[32] N. Bautista,et al. Prognosis and treatment of bile duct carcinoma. , 1998, The American surgeon.
[33] M. Nagasawa,et al. 12-O-Tetradecanoylphorbol-13acetate Activates the Ras/ Extracellular Signal-regulated Kinase (ERK) Signaling Pathway Upstream of SOS Involving Serine Phosphorylation of Shc in NIH3T3 Cells* , 1997, The Journal of Biological Chemistry.